Health information study to understand and prevent stomach cancer
Part of Cancer, Digestive system clinical trials.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You can read and understand English or Spanish.
- You fall into one of these three groups: 1) Have precancerous stomach changes (like gastric atrophy or intestinal metaplasia) or a history of early stomach cancer treated with endoscopy; 2) Are a healthy person having a routine endoscopy; or 3) Have early stomach cancer and are having surgery at MSK.
- You cannot have had certain genetic conditions (like Hereditary Diffuse Gastric Cancer Syndrome) or specific high-risk esophageal or duodenal lesions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at adults with stomach lining changes—either atrophic gastritis or intestinal metaplasia—and studies how to predict who may be at risk for stomach cancer. It may help earlier identification and closer monitoring for people with these conditions.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study looks for early warning changes in the stomach and aims to improve early detection and prevention. Depending on your situation, you may be grouped as having stomach symptoms, early lesions that might be removed, already-diagnosed stomach cancer, or a comparison group without stomach problems.
This study uses high-definition endoscopy to look at early changes in the stomach lining that might lead to cancer. It aims to better understand these changes in people having a routine upper endoscopy for stomach-related symptoms.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
Hear when a new Gastric Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.